Welcome to our dedicated page for REGIS SEC filings (Ticker: RGS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on REGIS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into REGIS's regulatory disclosures and financial reporting.
Regis Corp (RGS) reported an equity grant to one of its directors. On November 14, 2025, the director acquired 2,727 shares of common stock at a price of $0, increasing the director’s beneficial ownership to 5,479 shares held directly. The award is structured to vest on the earlier of November 14, 2026 or the company’s next annual shareholder meeting after November 14, 2025, provided the director continues to serve the company and meets the other conditions in the grant agreements.
Regis Corporation (RGS) reported a Form 4 showing that a company director received an award of 2,727 shares of common stock on November 14, 2025 at a price of $0 per share. Following this grant, the director beneficially owns 8,068 shares of Regis common stock in total. The award vests on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, contingent on the director’s continued service and the terms of the grant agreements.
Regis Corporation (RGS) reported an insider equity award to one of its directors. On 11/14/2025, the director acquired 2,727 shares of common stock at a price of $0, increasing their holdings to 5,927 shares held directly. The award is scheduled to vest on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, provided the director continues to serve the company and meets the other terms of the grant agreement.
Regis Corporation (RGS) reported an equity grant to one of its directors. On November 14, 2025, the director acquired 2,727 shares of common stock at a price of $0, increasing the director’s beneficial ownership to 8,114 shares, held directly. This was reported on a Form 4 filed for a single reporting person.
The shares were granted as an equity award that vests on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, provided the director continues to serve on the board and meets the other terms of the grant agreements. This reflects routine director compensation in stock rather than a market purchase.
Regis Corporation (RGS) reported that one of its directors received an award of 2,727 shares of common stock on November 14, 2025. The award was granted at a stated price of $0, indicating a stock grant rather than an open-market purchase.
After this grant, the director beneficially owns 13,567 shares in total. The shares vest on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, provided the director continues to serve the company and meets the other terms and conditions of the grant agreement.
Regis Corporation reported a return to profitability for the quarter ended September 30, 2025. Total revenue was $58.96 million, up from $46.06 million a year ago, driven by the December 2024 Alline acquisition which lifted company-owned salon revenue to $20.21 million (from $0.79 million). Operating income rose to $5.92 million as lower general and administrative costs offset higher rent and company-owned expenses.
After $5.27 million of interest expense and a $1.00 million gain from reducing the Alline earn-out liability, net income was $1.36 million, or $0.49 diluted EPS, compared with a loss last year. Cash from operations was $2.28 million. Cash and cash equivalents were $16.56 million; total available liquidity, net of the minimum liquidity covenant, was $25.5 million, with $19.0 million available under the revolver.
Franchise trends were softer: royalties fell to $14.04 million and franchise rent lines declined with fewer franchise salons, while system-wide same-store sales improved to 0.9%. Debt included a term loan of $117.04 million plus $6.78 million of paid-in-kind interest, maturing in 2029. Shares outstanding were 2,480,493 as of November 5, 2025.
Regis Corporation furnished an 8-K announcing financial results for its fiscal quarter ended September 30, 2025. The company noted that the information provided under Item 2.02 is furnished and not deemed filed, and it is not incorporated by reference into other filings.
Detailed figures and commentary are contained in the attached Exhibit 99.1 press release dated November 12, 2025.
Regis Corporation reported the results of its Annual Meeting held on October 28, 2025. Shareholders elected five directors and approved the advisory say‑on‑pay vote.
They ratified Grant Thornton LLP as independent auditor. The Amended and Restated 1991 Contributory Stock Purchase Plan was approved, and shareholders gave advisory ratification to extend the Tax Benefits Preservation Plan.
Key vote totals included: say‑on‑pay For 629,139; auditor ratification For 1,661,370; stock purchase plan For 609,366; tax benefits preservation plan extension For 702,830.
Form 144 for RGS (Regis Corp) notifies the market of a proposed sale of 437 common shares through Fidelity Brokerage Services (900 Salem St, Smithfield, RI) with an approximate sale date of 09/26/2025. The filing reports the shares were acquired under an option granted 05/05/2022 and payment is indicated as cash. The issuer's total shares outstanding are listed as 2,435,981, giving the proposed block an aggregate market value of $12,454.50. The filer also reported recent sales by the same person: 9/18/2025 — 9,626 shares for $278,342.53 and 9/19/2025 — 937 shares for $26,719.49. The signer attests there is no undisclosed material adverse information.
Form 144 notice for Regis Corp (RGS) shows a proposed sale of 937 common shares through Fidelity Brokerage Services with an aggregate market value of $26,719.50, to be sold approximately on 09/19/2025 on NASDAQ. The filing lists 2,435,981 shares outstanding for the class and indicates the securities were acquired under options granted on 05/05/2022 with payment in cash.
The filing also discloses that the same person previously sold 9,626 common shares on 09/18/2025 for gross proceeds of $278,342.53. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information about the issuer.